Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Non-Current Assets (2021 - 2025)

Medicinova (MNOV) has disclosed Non-Current Assets for 8 consecutive years, with $14.6 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets changed N/A to $14.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $58.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $14.6 million for FY2025, N/A changed from the prior year.
  • Non-Current Assets for Q4 2025 was $14.6 million at Medicinova, roughly flat from $14.7 million in the prior quarter.
  • The five-year high for Non-Current Assets was $25.2 million in Q3 2022, with the low at $14.6 million in Q4 2025.
  • Average Non-Current Assets over 5 years is $15.6 million, with a median of $15.1 million recorded in 2023.
  • The sharpest move saw Non-Current Assets surged 63.24% in 2022, then tumbled 40.02% in 2023.
  • Over 5 years, Non-Current Assets stood at $15.4 million in 2021, then soared by 63.94% to $25.2 million in 2022, then crashed by 40.2% to $15.1 million in 2023, then dropped by 1.6% to $14.9 million in 2024, then dropped by 1.63% to $14.6 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $14.6 million, $14.7 million, and $14.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.